An unexpectedly high incidence of Epstein–Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma

The risk of Epstein–Barr virus lymphoproliferative disease (EBV-LPD) increases with the use of highly immunosuppressive therapies. Allogeneic BMT, especially supported by T-cell-depleted stem cell products, is a risk factor for EBV-LPD. Although the risk of EBV-LPD after autologous transplantation i...

Descripción completa

Detalles Bibliográficos
Autores principales: Powell, J L, Bunin, N J, Callahan, C, Aplenc, R, Griffin, G, Grupp, S A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091929/
https://www.ncbi.nlm.nih.gov/pubmed/14730339
http://dx.doi.org/10.1038/sj.bmt.1704402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091929/
https://www.ncbi.nlm.nih.gov/pubmed/14730339
http://dx.doi.org/10.1038/sj.bmt.1704402

Ejemplares similares